These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

664 related articles for article (PubMed ID: 29288686)

  • 1. Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression.
    Roseman L; Demetriou L; Wall MB; Nutt DJ; Carhart-Harris RL
    Neuropharmacology; 2018 Nov; 142():263-269. PubMed ID: 29288686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression.
    Mertens LJ; Wall MB; Roseman L; Demetriou L; Nutt DJ; Carhart-Harris RL
    J Psychopharmacol; 2020 Feb; 34(2):167-180. PubMed ID: 31941394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression.
    Stroud JB; Freeman TP; Leech R; Hindocha C; Lawn W; Nutt DJ; Curran HV; Carhart-Harris RL
    Psychopharmacology (Berl); 2018 Feb; 235(2):459-466. PubMed ID: 29085980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.
    Carhart-Harris RL; Bolstridge M; Day CMJ; Rucker J; Watts R; Erritzoe DE; Kaelen M; Giribaldi B; Bloomfield M; Pilling S; Rickard JA; Forbes B; Feilding A; Taylor D; Curran HV; Nutt DJ
    Psychopharmacology (Berl); 2018 Feb; 235(2):399-408. PubMed ID: 29119217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amygdala excitability to subliminally presented emotional faces distinguishes unipolar and bipolar depression: an fMRI and pattern classification study.
    Grotegerd D; Stuhrmann A; Kugel H; Schmidt S; Redlich R; Zwanzger P; Rauch AV; Heindel W; Zwitserlood P; Arolt V; Suslow T; Dannlowski U
    Hum Brain Mapp; 2014 Jul; 35(7):2995-3007. PubMed ID: 24038516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blunted amygdala activity is associated with depression severity in treatment-resistant depression.
    Ferri J; Eisendrath SJ; Fryer SL; Gillung E; Roach BJ; Mathalon DH
    Cogn Affect Behav Neurosci; 2017 Dec; 17(6):1221-1231. PubMed ID: 29063521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emotions and brain function are altered up to one month after a single high dose of psilocybin.
    Barrett FS; Doss MK; Sepeda ND; Pekar JJ; Griffiths RR
    Sci Rep; 2020 Feb; 10(1):2214. PubMed ID: 32042038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psilocybin modulates functional connectivity of the amygdala during emotional face discrimination.
    Grimm O; Kraehenmann R; Preller KH; Seifritz E; Vollenweider FX
    Eur Neuropsychopharmacol; 2018 Jun; 28(6):691-700. PubMed ID: 29703645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does a single session of electroconvulsive therapy alter the neural response to emotional faces in depression? A randomised sham-controlled functional magnetic resonance imaging study.
    Miskowiak KW; Kessing LV; Ott CV; Macoveanu J; Harmer CJ; Jørgensen A; Revsbech R; Jensen HM; Paulson OB; Siebner HR; Jørgensen MB
    J Psychopharmacol; 2017 Sep; 31(9):1215-1224. PubMed ID: 28351201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-Dose Synthetic Psilocybin With Psychotherapy for Treatment-Resistant Bipolar Type II Major Depressive Episodes: A Nonrandomized Open-Label Trial.
    Aaronson ST; van der Vaart A; Miller T; LaPratt J; Swartz K; Shoultz A; Lauterbach M; Sackeim HA; Suppes T
    JAMA Psychiatry; 2024 Jun; 81(6):555-562. PubMed ID: 38055270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased low-frequency brain responses to music after psilocybin therapy for depression.
    Wall MB; Lam C; Ertl N; Kaelen M; Roseman L; Nutt DJ; Carhart-Harris RL
    J Affect Disord; 2023 Jul; 333():321-330. PubMed ID: 37094657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.
    Carhart-Harris RL; Bolstridge M; Rucker J; Day CM; Erritzoe D; Kaelen M; Bloomfield M; Rickard JA; Forbes B; Feilding A; Taylor D; Pilling S; Curran VH; Nutt DJ
    Lancet Psychiatry; 2016 Jul; 3(7):619-27. PubMed ID: 27210031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin.
    Carhart-Harris RL; Leech R; Williams TM; Erritzoe D; Abbasi N; Bargiotas T; Hobden P; Sharp DJ; Evans J; Feilding A; Wise RG; Nutt DJ
    Br J Psychiatry; 2012 Mar; 200(3):238-44. PubMed ID: 22282432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain activation in response to overt and covert fear and happy faces in women with borderline personality disorder.
    Cullen KR; LaRiviere LL; Vizueta N; Thomas KM; Hunt RH; Miller MJ; Lim KO; Schulz SC
    Brain Imaging Behav; 2016 Jun; 10(2):319-31. PubMed ID: 26007149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression.
    Carrillo F; Sigman M; Fernández Slezak D; Ashton P; Fitzgerald L; Stroud J; Nutt DJ; Carhart-Harris RL
    J Affect Disord; 2018 Apr; 230():84-86. PubMed ID: 29407543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial.
    Davis AK; Barrett FS; May DG; Cosimano MP; Sepeda ND; Johnson MW; Finan PH; Griffiths RR
    JAMA Psychiatry; 2021 May; 78(5):481-489. PubMed ID: 33146667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of psilocybin in depressive disorders.
    Najib J
    Curr Med Res Opin; 2024 Oct; 40(10):1793-1808. PubMed ID: 39177339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different neural and cognitive response to emotional faces in healthy monozygotic twins at risk of depression.
    Miskowiak KW; Glerup L; Vestbo C; Harmer CJ; Reinecke A; Macoveanu J; Siebner HR; Kessing LV; Vinberg M
    Psychol Med; 2015 May; 45(7):1447-58. PubMed ID: 25382193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neural correlates of perception of emotional facial expressions in out-patients with mild-to-moderate depression and anxiety. A multicenter fMRI study.
    Demenescu LR; Renken R; Kortekaas R; van Tol MJ; Marsman JB; van Buchem MA; van der Wee NJ; Veltman DJ; den Boer JA; Aleman A
    Psychol Med; 2011 Nov; 41(11):2253-64. PubMed ID: 21557888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in music-evoked emotion and ventral striatal functional connectivity after psilocybin therapy for depression.
    Shukuroglou M; Roseman L; Wall M; Nutt D; Kaelen M; Carhart-Harris R
    J Psychopharmacol; 2023 Jan; 37(1):70-79. PubMed ID: 36433778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.